A Nature Reviews Bioengineering review examines how tissue engineering, stem cell transplantation and gene-based approaches could advance in utero treatment of congenital and genetic disorders. Congenital and genetic disorders often cause death or lifelong disability, and treatments delivered after birth…
Can we grow accurate biological versions of human embryos? Not yet, but we're getting closer University of Sydney researchers have developed a powerful new way to test how closely lab-grown biological models resemble real human embryos, finding that while some…
A map built from more than 14,000 embryo cells reveals what stem cell models get right about early human development and where researchers could improve them. Under a microscope, a cluster grown from stem cells can resemble a human embryo in…
The rapid advancements in genetic engineering have opened up new possibilities for medical treatments and disease prevention. One of the most controversial applications of this technology is the potential to create "designer babies" – children whose genetic makeup has been altered…
Researchers at EMBL Rome developed a precision in vitro fertilisation protocol to obtain unprecedented insight into embryonic genome activation in mammals. Their work reveals previously unknown patterns in genes activated during the earliest moments of mammalian development A new study…
Finds Bioengineer.org
BERLIN - A patient in Germany has been successfully treated with a drug based on the CRISPR gene-editing technology for the first time, the Charité medical school and hospital in Berlin announced on Thursday. The 19-year-old patient, Mohammad, has the genetic…
Science regularly helps couples who want children. Millions rely on clinics to start their families. Now, a controversial leap in laboratory technology threatens to cross a permanent line. Eight years ago, the scientific world reeled when He Jiankui revealed he…
Custom Medicine Engineered for an Infant's Specific DNA: Can Individualized Treatments Now Be Built Newstrack English In medical science, the conventional paradigm involves first manufacturing a drug and subsequently identifying the thousands or millions of patients who might benefit from…
Origin founder and CEO Katie T believes that modern genome editing technologies could one day transform the treatment of inherited diseases. However, scientists and bioethicists warn of serious risks and ethical concerns. Katie T wears a white lab coat with…
The ethics of editing human embryos and heritable DNA: the debate and the rules, the companies proposing it, the scientists opposing it, and the limits on embryo research.
An article joins this feed when it matches these terms. Each one is also a search of its own.